Gross, B., Matesanz, SE., Kichula, EA. Shortening Treatment Initiation Timeframe Through Prenatal/Neonate Genetic Diagnosis of Spinal Muscular Atrophy. Philadelphia Prenatal Conference. Virtual presentation due to COVID19 pandemic.
Matesanz, SE., Kichula, EA., Brandsema, JF., Yum, SW. Muscle ultrasound as a tool for identification of early disease manifestation in SMA patients identified by newborn screen. Accepted to the Muscular Dystrophy Association 2020 Annual Conference; March 2020 in Orlando, FL. Conference cancelled due to COVID-19.
Matesanz, SE*., Edelson, JB*., Iacobellis, KA., Mejia, E., Brandsema, JF., Griffis, H., Okunowo, O. Lin, KY. Characteristics of Healthcare Users in Pediatric Patients with Muscular Dystrophy in the United States. Accepted to the Muscular Dystrophy Association 2020 Annual Conference; March 2020 in Orlando, FL. *co-first authors. Conference cancelled due to COVID-19.
Edelson, J., Matesanz, S., Iacobellis, K., Mejia, E., Brandsema, J., Griffis, H., Okunowo, O. Lin, K. Health Care Utilization in Pediatric Patients with Muscular Dystrophy in the United States. J Am Coll Cardiol. 2020 Mar, 75 (11 Supplement 1) 1096.
Matesanz, S., Brandsema, J., Mayer, O., Kichula, E. Comparing Hospital Respiratory Outcomes Pre- and Post- Nusinersen Treatment in Children with Spinal Muscular Atrophy. Presented at the Child Neurology Society Annual Conference, Charlotte NC, October 2019. Annals of Neurology Vol 86 (suppl 23) 2019. S125.181.
Hopkins, S., Gordon-Lipkin, E., VanHaren, K., Santoro, J., Munoz-Arcos, L., Matesanz, S., et al. MRI Brain Abnormalities in Acute Flaccid Myelitis: Characteristics and Differentiation from Acute Disseminated Encephalomyelitis. Presented at American Academy of Neurology annual meeting 2018. Neurology Apr 2018, 90 (15 Supplement) P5.145
Posters and Presentations
Matesanz, SE., Battista, V., Jones, J., Flickinger, J., Kichula, EA. Early Single Center Clinical Experience with Onasemnogene Abeparvovec-xioi in Spinal Muscular Atrophy (SMA) Type 1 and 2 Patients over Age 7 Months. Oral presentation at virtual CureSMA conference.
Matesanz, SE., Curry C., Gross B., Rubin, AI., Linn, R., Yum SY., Kichula, EA. Clinical Course in a Patient with Spinal Muscular Atrophy Type 0 Treated with Nusinersen and Onasemnogene Abeparvovec. J Child Neurol. In press. doi:10.1177/0883073820928784
Cuddapah, V., Matesanz, S., Yum, S., Banwell, B., Stephenson, D. Peripheral Neuropathy Caused by Vitamin B12 Deficiency: Vitamin B12 Deficiency was Precipitated by Nitrous Oxide in a Child with Autism. Pract Neurol. Mar/Apr 2020: 64-67.
Matesanz, S., McGuire, J., & Hopkins, S. Acute Flaccid Myelitis: Characteristics and Outcomes of 2014 and 2016 Cases at a Single Center. J Pediatr 2019;215:272-6. doi: 10.1016/j.jpeds.2019.07.015.
Matesanz, S., Kotch, C., Perrone, C., Waanders,A., Hill, B., Narula, S. Expanding the MOG Phenotype: Brainstem Encephalitis with punctate and curvilinear enhancement. Neurology: Neuroimmunology and Neuroinflammation. Neurol Neuroimmunol Neuroinflamm. 2019 Sep 13;6(6). pii: e619. doi: 10.1212/NXI.0000000000000619. Print 2019 Nov.
Maza, M., Matesanz, S., et al. Adherence to recommended follow-up care after high grade cytology in El Salvador. International Journal of Healthcare 2: 31-36, 2016.
Awards and Honors
2008, Cum Laude, Dartmouth College
2007-2008, Rufus Choate Scholar, GPA in Top 5% of Class at Dartmouth College for the academic year
2006, James O. Freedman Presidential Research scholar
Patient Experience Ratings
About the Patient Experience Rating System
The Patient Experience Rating is an average of all responses to the care provider related questions shown above from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
We are committed to true transparency. However, to ensure the comments are fair and correctly attributed, we review each one before posting to the website. We exclude entire comments that disclose patient's protected health information, are off-topic, or include other confidential or inappropriate content. Comments will appear on provider bios only if providers have a minimum number of comments.
Comments are shared internally for education purposes to ensure that we are doing our very best for the patients and families for whom we are privileged to care.
The comments are submitted by patients and families and reflect their views and opinions. The comments are not endorsed by and do not reflect the views of Children’s Hospital of Philadelphia.